MAdCAM-1 showed a comparable expression pattern than CD62L with significantly lower expression in steatosis patients compared to the NASH group, especially when the amount of fat is <30% (Figure S1B–D). Here, MADCAM1 is linked to metabolic dysfunction-associated steatohepatitis.